CANF - Can-Fite BioPharma Ltd.

QQQ $ 594.23 $ 0.00 (0 %)

DIA $ 463.51 $ 0.00 (0 %)

SPY $ 662.22 $ 0.00 (0 %)

TLT $ 90.00 $ 0.00 (0 %)

GLD $ 375.35 $ 0.00 (0 %)

Previous Close

$ 0.292

Open

$ 0.30

Bid

$ 0.29 x 5

Ask

$ 0.30 x 250

Day's Range

-- - --

52 Week Range

$ 0.28 - $ 2.35

Volume

2,642,705

Average Volume

Market Cap

Beta (5Y Monthly)

$ 0.98

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Can-Fite Aims To Advance Second Veterinary...
11/24/2025 12:05:50

Can-Fite Secures Brazilian Patent for Erec...
11/20/2025 12:04:03

Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule d...

D. Boral Capital Maintains Buy on Can Fite...
11/18/2025 19:30:54

D. Boral Capital analyst Jason Kolbert maintains Can Fite Biofarma (AMEX:CANF) with a Buy and maintains $11 price target.

Nasdaq Down 1%; Medtronic Earnings Top Views
11/18/2025 17:53:00

dow-falls-over-300-points-home-depot-posts-downbeat-earnings

Dow Falls Over 300 Points; Home Depot Post...
11/18/2025 14:55:54

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
11/18/2025 12:06:25

Can-Fite Reports 9-Year Complete Cure In A...
11/18/2025 12:06:06

Can-Fite BioPharma Announces Patients Trea...
11/18/2025 12:05:48

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small m...

HC Wainwright & Co. Assumes Can Fite Biofa...
11/04/2025 11:39:45

HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Can Fite Biofarma (AMEX:CANF) with a Buy rating and announces...

12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 12:09:34

D. Boral Capital Maintains Buy on Can Fite...
09/16/2025 11:03:59

D. Boral Capital analyst Jason Kolbert maintains Can Fite Biofarma (AMEX:CANF) with a Buy and maintains $11 price target.

Can-Fite Highlights Potential Of Namodenos...
09/15/2025 11:06:51

12 Health Care Stocks Moving In Friday's P...
08/22/2025 12:08:33

Can-Fite Hits 50% Enrollment In Phase 2a P...
07/30/2025 11:08:13

D. Boral Capital Maintains Buy on Can Fite...
07/29/2025 13:18:04

D. Boral Capital analyst Jason Kolbert maintains Can Fite Biofarma (AMEX:CANF) with a Buy and maintains $10 price target.

12 Health Care Stocks Moving In Monday's I...
07/28/2025 17:06:06

Can-Fite Biopharma Shares Resume Trade
07/28/2025 16:40:36

Can-Fite Prices $5M Public Offering Of 8.3...
07/28/2025 16:28:59

Can-Fite BioPharma Ltd.

Can-Fite Biopharma Shares Halted On Code N...
07/28/2025 16:26:41

Can-Fite's Piclidenoson Shows Effect in UC...
07/28/2025 11:08:06

Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary s...